Clinical trial
Tacrolimus Treatment of Patients With Idiopathic Focal Segmental
NCT00302536 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tacrolimus Treatment of Patients With Idiopathic Focal Segmental
- Lead sponsor
- Nanjing University School of Medicine
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- March 31, 2006
- Completion date
- September 30, 2010
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
focal glomerulosclerosis